Get the Stockscreener App
1.70
1.45%
-0.025
After Hours:
1.70
InspireMD Inc. stock is traded at $1.70, with a volume of 15,368.
It is down -1.45% in the last 24 hours and up +4.94% over the past month.
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms in order to seal the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.
See More
Previous Close:
$1.725
Open:
$1.69
24h Volume:
15,368
Relative Volume:
0.18
Market Cap:
$72.03M
Revenue:
$6.21M
Net Income/Loss:
$-19.92M
P/E Ratio:
-1.619
EPS:
-1.05
Net Cash Flow:
$-16.76M
1W Performance:
+3.66%
1M Performance:
+4.94%
6M Performance:
-32.54%
1Y Performance:
-39.50%
1-Day Range:
$1.65
$1.725
1-Week Range:
$1.6201
$1.8349
52-Week Range:
$1.51
$3.798
InspireMD Inc. Stock (NSPR) Company Profile
Name
InspireMD Inc.
Sector
Industry
Phone
972 3 6917691
Address
4 Menorat Hamaor Street, Tel Aviv
Compare NSPR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
1.70 | 73.09M | 6.21M | -19.92M | -16.76M | -1.05 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-02-26 | Initiated | Maxim Group | Buy |
| Jan-07-16 | Initiated | Rodman & Renshaw | Buy |
| Mar-13-15 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-26-13 | Initiated | Oppenheimer | Outperform |
InspireMD Inc. Stock (NSPR) Latest News
Aberdeen Group plc Expands Stake in InspireMD Inc with Strategic Acquisition - GuruFocus
Gains Report: Why is InspireMD Inc stock going upMarket Trend Summary & Daily Price Action Insights - baoquankhu1.vn
This Insider Has Just Sold Shares In InspireMD - simplywall.st
InspireMD (NYSE:NSPR) Now Covered by Maxim Group - Defense World
InspireMD CCO Gleason sells $99k in NSPR stock By Investing.com - Investing.com South Africa
InspireMD (NYSE:NSPR) Insider Shane Thomas Gleason Sells 8,411 Shares - MarketBeat
Shane Thomas Gleason Sells 17,593 Shares of InspireMD (NYSE:NSPR) Stock - MarketBeat
Shane Thomas Gleason Sells 12,395 Shares of InspireMD (NYSE:NSPR) Stock - MarketBeat
InspireMD CCO Gleason sells $99k in NSPR stock - Investing.com
Aug Spikes: Why is InspireMD Inc stock going upJuly 2025 Breakouts & High Accuracy Trade Alerts - baoquankhu1.vn
Rate Cut: Is InspireMD Inc part of any ETFJuly 2025 Movers & Precise Entry and Exit Recommendations - baoquankhu1.vn
Jobs Data: Why is InspireMD Inc stock going upBear Alert & Weekly Momentum Stock Picks - baoquankhu1.vn
InspireMD (NYSE:NSPR) versus Motus GI (NASDAQ:MOTS) Critical Contrast - Defense World
InspireMD (NYSE:NSPR) Stock Price Down 1.8%Should You Sell? - MarketBeat
One new InspireMD hire gets 36,118-share inducement grant - Stock Titan
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire Inc.
Performance Recap: Is M tron Industries Inc stock a good dividend stockDividend Hike & Fast Gain Stock Trading Tips - baoquankhu1.vn
Wall Street Recap: Can InspireMD Inc keep up with sector leadersVolume Spike & Consistent Return Strategy Ideas - baoquankhu1.vn
Buyback Watch: Is InspireMD Inc stock risky to hold nowQuarterly Portfolio Summary & High Accuracy Swing Trade Signals - baoquankhu1.vn
Options Flow: Can InspireMD Inc be recession proofJuly 2025 Intraday Action & Fast Moving Stock Watchlists - baoquankhu1.vn
InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC) - The Manila Times
InspireMD's CGuard® Prime Carotid Stent System Achieves Landmark Safety and Efficacy Results in C-GUARDIANS Trial Published in JACC - Quiver Quantitative
New carotid stent study reports low stroke rates for high-risk patients - Stock Titan
Chipmakers Recap: Can InspireMD Inc outperform in the next rally2025 Growth vs Value & Daily Chart Pattern Signals - baoquankhu1.vn
Published on: 2026-01-10 23:14:00 - Улправда
InspireMD (NASDAQ:NSPR) shareholders have endured a 81% loss from investing in the stock five years ago - Yahoo Finance
Will InspireMD Inc. (II2) stock outperform value peersProfit Target & Expert Approved Momentum Trade Ideas - Улправда
Why InspireMD Inc. stock could be next big winnerPortfolio Performance Report & Growth Focused Stock Reports - ulpravda.ru
Will InspireMD Inc. stock continue dividend increasesMarket Growth Report & Advanced Technical Signal Analysis - Улправда
Will InspireMD Inc. (II2) stock benefit from sector leadership2025 Macro Impact & Weekly Return Optimization Alerts - Улправда
How InspireMD Inc. stock compares to growth peersTrade Exit Summary & Daily Entry Point Trade Alerts - Улправда
InspireMD (NYSE:NSPR) Trading Down 6.2%Should You Sell? - MarketBeat
InspireMD (NYSE:NSPR) Trading Down 6.2% – Should You Sell? - Defense World
InspireMD (NSPR) price target decreased by 11.11% to 4.08 - MSN
Head to Head Analysis: InspireMD (NYSE:NSPR) versus Minerva Surgical (NASDAQ:UTRS) - Defense World
Is InspireMD (NASDAQ:NSPR) In A Good Position To Invest In Growth? - Sahm
Will InspireMD Inc. stock gain from lower inflationWeekly Trade Analysis & Low Risk Entry Point Guides - Улправда
Working capital per share of InspireMD Inc. – DUS:II2 - TradingView — Track All Markets
Can InspireMD Inc. stock hit record highs again2025 Breakouts & Breakdowns & Stepwise Swing Trade Plans - Улправда
Aug Update: Will InspireMD Inc. (II2) stock outperform value peersJuly 2025 Catalysts & Safe Capital Preservation Plans - Улправда
Why InspireMD Inc. stock is considered a top pickJuly 2025 Highlights & Weekly High Return Forecasts - Улправда
Will InspireMD Inc. (II2) stock profit from fiscal stimulusBreakout Watch & Verified Momentum Watchlists - Улправда
InspireMD’s new study on neuroprotection system: A potential game-changer? - MSN
Is InspireMD Inc a good long term investmentREITs Market Trends & Capital Efficiency Improvement - earlytimes.in
InspireMD’s Pivotal Study on CGuard Prime Stent System: A Potential Game-Changer - MSN
InspireMD’s New Study on Neuroprotection System: A Potential Game-Changer? - TipRanks
InspireMD Inc. Stock (NSPR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):